Cresendo Pharmaceuticals Private Limited

Pharmaceutical trading company established in 2016, based in Hyderabad, Telangana.

2016 | Hyderabad, Telangana (India) | Active
Last Updated:

Cresendo Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 9 Year, 4 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 146.40%
  • Profit Growth 262.86%
  • Ebitda 6333.76%
  • Net Worth 5.77%
  • Total Assets 11.61%

About Cresendo Pharmaceuticals

Cresendo Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 January 2016 (Nine years and four months 3 days old ). Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.

Pradeep Pendyala and Venkat Balanagari serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U51101TG2016PTC102651

  • Company No.

    102651

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    08 Jan 2016

  • Date of AGM

    29 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma
Company report

Cresendo Pharmaceuticals Private Limited

Explore comprehensive data for Cresendo Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Cresendo Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Pradeep Pendyala Country flag representing In Director 08-Jan-2016Current
Venkat Balanagari Country flag representing In Director 08-Jan-2016Current

Financial Performance of Cresendo Pharmaceuticals.

Cresendo Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 146.4% increase. The company also saw a substantial improvement in profitability, with a 262.86% increase in profit. The company's net worth moved up by a moderate rise of 5.77%.

Cresendo Pharmaceuticals revenue growth over time
Cresendo Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
146.40%
Revenue from Operations
146.40%
Total Assets
11.61%
Profit or Loss
262.86%
Net Worth
5.77%
EBITDA
6333.76%

What is the Ownership and Shareholding Structure of Cresendo Pharmaceuticals?

Unlock access to Cresendo Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Cresendo Pharmaceuticals?

Unlock and access historical data on people associated with Cresendo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Cresendo Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cresendo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cresendo Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Cresendo Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Cresendo Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Cresendo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.

  • Director Appointment

    Pradeep Pendyala was appointed as a Director was appointed as a Director on 08 Jan 2016 & has been associated with this company since 9 years 4 months .

  • Director Appointment

    Venkat Reddy Balanagari was appointed as a Director was appointed as a Director on 08 Jan 2016 & has been associated with this company since 9 years 4 months .

  • Company Incorporation

    Cresendo Pharmaceuticals Private Limited was registered on 08 Jan 2016 with Roc Hyderabad & aged 9 years 4 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Cresendo Pharmaceuticals Private Limited?

    Cresendo Pharmaceuticals Private Limited was incorporated on 08 Jan 2016.

  • What is authorized share capital and paid-up capital of Cresendo Pharmaceuticals Private Limited?

    The authorized share capital of Cresendo Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.20 M.

  • Who are the current board members & directors of Cresendo Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Cresendo Pharmaceuticals Private Limited.

    • Pradeep Pendyala
    • Venkat Reddy Balanagari
  • What is the registered address of Cresendo Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Cresendo Pharmaceuticals Private Limited is Plot No M73 To M79 1St Floor Surya Prakash Complex Opp.Swapnatheatre Backside Tsiic Office, Kattendhan India, Hyderabad, Telangana, 500077.

  • What is the corporate identification number (CIN) and company number of Cresendo Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Cresendo Pharmaceuticals Private Limited is U51101TG2016PTC102651 and the company number is 102651 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Cresendo Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Cresendo Pharmaceuticals Private Limited has risen by 146.40%.

  • What change has been observed in the net worth of Cresendo Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Cresendo Pharmaceuticals Private Limited has experienced an upsurge of 5.77%.

  • When was the last Balance Sheet of Cresendo Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Cresendo Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial